FDA Inspection 1298554 — Seattle Reproductive Medicine, PLLC

Seattle Reproductive Medicine, PLLC — FEI 3005187125

The FDA completed an inspection of Seattle Reproductive Medicine, PLLC on January 14, 2026 in Kirkland, WA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
January 14, 2026
Fiscal Year
2026
Product Type
Biologics
Project Area
Human Cellular, Tissue, and Gene Therapies
Location
Kirkland, WA (United States)